STOCK TITAN

Gilead Sciences Inc (GILD) Free Cash Flow by Year

GILD

Gilead Sciences Inc generated $9.5B in free cash flow in fiscal year 2025. This represents a decrease of 8.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $12.9B in free cash flow. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Gilead Sciences Inc has filed alongside them.

FY2025 annual
Free Cash Flow $9.5B
YoY -8.2%
5Y CAGR +4.7%
10Y CAGR -7.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

GILD Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Free Cash Flow$12.9B$9.5B-8.2%$10.3B+38.9%$7.4B-11.1%$8.3B-22.8%$10.8B+43.7%$7.5B-9.6%$8.3B+11.3%$7.5B-33.9%$11.3B-30.6%$16.3B-20.5%$20.5B+67.2%$12.3B+312.7%$3.0B+6.2%$2.8B-20.2%$3.5B

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

GILD Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash Flow$3.4B+376.8%$2.4B+46.8%$3.1B+10.4%$4.0B-5.0%$720.0M-39.7%$1.7B-21.8%$2.8B+44.7%$4.2B+155.2%$1.2B-45.7%$2.1B+29.3%$2.0B-18.1%$1.6B-39.7%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Gilead Sciences Inc financials

Frequently Asked Questions

What was Gilead Sciences Inc's free cash flow in fiscal year 2025?

Gilead Sciences Inc generated $9.5B in free cash flow in fiscal year 2025.

How fast is Gilead Sciences Inc's free cash flow growing?

Gilead Sciences Inc (GILD) free cash flow fell by 8.2% year over year, from $10.3B to $9.5B in fiscal year 2025.

What is Gilead Sciences Inc's free cash flow over the last twelve months?

Gilead Sciences Inc (GILD) reported $12.9B in free cash flow over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Gilead Sciences Inc (GILD) free cash flow went from $3.5B in fiscal year 2011 to $9.5B in fiscal year 2025.

Gilead Sciences Inc (GILD) reported $3.4B in free cash flow in Q2 2026. This represents an increase of 376.8% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Gilead Sciences Inc (GILD) reported on that line in every period on record.